Considering that the overexpression of GPER is crucial in the progression of breast cancer, further studies (aside from those discussed in the previous paragraph) were carried out to investigate in greater detail the molecular mechanisms by which ERα17p may engage the GPER transduction pathway. Here, GPER1 is linked to breast cancer.